873 Mapping the current service availability in paediatric gastroenterology networks across the United Kingdom: is there a postcode lottery in service provision?

Abstract

We have a dedicated LISA guideline which provides guidance on surfactant administration to babies on the Neonatal Unit, with surfactant deficiency who are self ventilating on non-invasive ventilation with nCPAP, optiflow or vapotherm.Eligibility criteria are as follow:. Babies 27 weeks and above (singletons) . or 28 weeks and above of multiple births, who do not require invasive ventilation/transfer to tertiary centre, with surfactant deficiency are eligible for LISA. . Babies 27 to 28 weeks gestation in >3o% oxygen and rising at age 2 hours on nCPAP. . Babies 29weeks gestation and above in > 30% oxygen and rising at age 6 hours on . CPAP are likely to benefit from surfactant as they are at risk of CPAP failure. LISA can be considered.